Cosmo and Glenmark announce the signing of Agreements for Winlevi
27 Sep 2023 //
PR NEWSWIRE
Hyphens Pharma licenses Winlevi® for all 10 ASEAN countries from Cosmo
23 Dec 2022 //
PR NEWSWIRE
Sun Pharma and Cosmo announce territory expansion of agreements for WINLEVI
26 Jul 2022 //
EXPRESS PHARMA
Cosmo Pharmaceuticals N.V. and Cassiopea S.p.A. publish
02 Dec 2021 //
COSMOPHARMA
Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi
26 Jul 2021 //
PRESS RELEASE
Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi
26 Jul 2021 //
PRESS RELEASE
COSMO PHARMACEUTICALS ANNOUNCES A CHANGE IN ITS BOARD OF DIRECTORS
10 May 2021 //
PRESS RELEASE
RedHill and Cosmo Strengthen Manufacturing Agreements
19 Feb 2021 //
CONTRACTPHARMA
COSMO ANNOUNCES LICENSE OF LUMEBLUE™ (METHYLENE BLUE MMX) EU RIGHTS TO ALFASIGMA
05 Feb 2021 //
PRESS
RedHill and Cosmo Expand Opaganib Manufacturing Deal
02 Feb 2021 //
CONTRACTPHARMA
RedHill-Partner Cosmo Pharmaceuticals schließt erfolgreich Ph-2-Studie
14 Jan 2021 //
PRNEWSWIRE
COSMO PHARMACEUTICALS ANNOUNCES LICENCE OF LUMEBLUE™
04 Dec 2020 //
PRESS RELEASE
COSMO PHARMACEUTICALS ANNOUNCES APPROVAL OF ELEVIEW® IN JAPAN
18 Nov 2020 //
PRESS RELEASE
RedHill and Cosmo Pharmaceuticals Expand Strategic Partnership
12 Aug 2020 //
CONTRACTPHARMA
COSMO PHARMACEUTICALS ANNOUNCES GRANTING OF MARKETING AUTHORIZATION IN ITALY
08 Jul 2020 //
PRESS RELEASE
Cosmo Pharmaceuticals Announces US FDA Approval of BYFAVO™
02 Jul 2020 //
PRESS RELEASE
Cosmo receives positive EMA CHMP Opinion recommending approval
26 Jun 2020 //
PRESS RELEASE
Cosmo`s announces the retirement of Chris Tanner from executive role
25 Feb 2020 //
PRESS RELEASE
Issue of Equity on Share Subscription and Licensing agreement With Cosmo
13 Jan 2020 //
GLOBENEWSWIRE
GHO Capital Acquires Ardena, a Leading CDMO
09 Jan 2020 //
BUSINESS WIRE
Hana Pharm submits NDA for anesthetic agent
31 Dec 2019 //
BIOSPECTRUMASIA